Semaglutide, found in Ozempic® and Wegovy®, is a highly effective option for sustainable weight loss. This non-habit-forming treatment boasts minimal side effects and has demonstrated remarkable results, with patients shedding an average of 17% of their body weight over 68 weeks, with 1 in 3 patients achieving a weight loss of over 20%.
*Benefits of GLP-1 medications (with proper diet and exercise)
*Patient must qualify for weight loss prescription based on provider’s evaluation.
Tirzepatide, found in Zepbound™ and Mounjaro®, represents the latest and most potent medication in the GLP-1 class for sustained weight loss. In clinical studies, when paired with a reduced-calorie diet and heightened physical activity, patients have achieved an impressive average weight reduction of 24% over 72 weeks.
*Benefits of GLP-1 medications (with proper diet and exercise)
*Patient must qualify for weight loss prescription based on provider’s evaluation.
Sign up to hear from us.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.